Challenges with Conventional Production Methods:

  • INCONSISTENT RESULTS
    Leads to poor-quality particles and unreliable data

  • INABILITY TO CONTROL SIZE
    Materials dictate size, making comparison of activity between materials difficult

  • LIMITED PRODUCTIVITY
    Long, complex procedures lengthen the production time, and increase the risk of process failure/error

  • COSTLY SCALE-UP
    Scaling up affects the properties of formulations, requiring expensive, time-consuming process redevelopment

  • REQUIRES EXPERTISE
    Projects require experienced specialists, long training periods, and carry significant risks with staff change

How does it work? Rapid Formulation.

Specifications

  • REPRODUCIBILITY
    High batch-to-batch reproducibility.

  • CONTROLLED ASSEMBLY
    Particles with identical composition can be sized tuned.

  • SCALABILITY
    Proprietary microfluidic platform allows discovery to GMP lab scale production.

Tracking Over Time (mL)
DPPC:Cholesterol:DOTAP
  • SIMPLE
    Simple set-up and easy to use, no complex fluidic connections.

  • HIGH THROUGHPUT
    40-50 formulations can be prepared in a day wit NeoNANOTMSinglex wells.

  • USER AGNOSTIC
    Not user dependent, requires no specialized training.

NeoNano+: Scale-up